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Abstract
Background: Ultraconserved elements (UCEs) are highly constrained elements of mammalian genomes, whose
functional role has not been completely elucidated yet. Previous studies have shown that some of them act as
enhancers in mouse, while some others are expressed in both normal and cancer-derived human tissues. Only one
UCE element so far was shown to present these two functions concomitantly, as had been observed in other
isolated instances of single, non ultraconserved enhancer elements.
Results: We used a custom microarray to assess the levels of UCE transcription during mouse development and
integrated these data with published microarray and next-generation sequencing datasets as well as with newly
produced PCR validation experiments. We show that a large fraction of non-exonic UCEs is transcribed across all
developmental stages examined from only one DNA strand. Although the nature of these transcripts remains a
mistery, our meta-analysis of RNA-Seq datasets indicates that they are unlikely to be short RNAs and that some of
them might encode nuclear transcripts. In the majority of cases this function overlaps with the already established
enhancer function of these elements during mouse development. Utilizing several next-generation sequencing
datasets, we were further able to show that the level of expression observed in non-exonic UCEs is significantly
higher than in random regions of the genome and that this is also seen in other regions which act as enhancers.
Conclusion: Our data shows that the concurrent presence of enhancer and transcript function in non-exonic UCE
elements is more widespread than previously shown. Moreover through our own experiments as well as the use of
next-generation sequencing datasets, we were able to show that the RNAs encoded by non-exonic UCEs are likely
to be long RNAs transcribed from only one DNA strand.
Background
Ultraconserved elements (UCE) have been defined as
segments spanning at least 200 base pairs and showing
100% identity between the human, mouse and rat gen-
omes. Further analysis of the distribution of UCEs
demonstrates that they tend to be organized in clusters,
in regions that are enriched for transcription factors and
developmental genes [1]. They have been suggested to
be important for functions involving DNA binding,
RNA processing and the regulation of transcription and
development [2-4], as well as being depleted in regions
containing copy number variants [5]. However, our
knowledge on these elements is still limited. The
mechanisms responsible for maintaining these sequences
through evolution are unclear but seem likely to include
profound negative selection, suggesting that these seg-
ments have important, if not vital, functions [6,7].
Recent studies provide conflicting evidence on their
functional role: although it has been shown that many
of these elements act as long-range enhancers during
mouse development [8], this function is not found for
all elements tested and it has been shown that similar
proportions of functional enhancers can be found in less
constrained sequences [9]. Moreover, deletion of some
of these regions in knock-out mice was not associated
to any notable phenotype abnormality [10]. These
results provided grounds to speculate that UCEs might
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any medium, provided the original work is properly cited.be simply due to “mutational cold spots”, yet it has been
shown that these regions are ultraselected [6]. Finally it
has also been shown that a larger number of regions in
the genome, although shorter, are under similar evolu-
tionary constraints [11].
Recently it has also been shown that some UCEs are
expressed and their expression is altered in human
tumors, suggesting that these elements may also be
involved in cancer development [12]. The transcription of
non-coding RNAs from genomic regions acting as enhan-
cers has already been shown to occur in elements with sig-
nificant sequence conservation, although little is known
about the mechanism involved. Indeed the functions of
promoter, enhancer and non-coding RNA have been
found to overlap in the same DNA fragments with 85-90%
mammalian conservation [13] as well as in one UCE [14].
Despite these many findings, the level of constraint
observed in UCEs remains as yet unexplained. We
decided to further investigate the extent of transcription
of UCEs by using an ad-hoc developed microarray as
well as several next-generation sequencing datasets. By
hybridizing the microarray with total RNA from differ-
ent mouse embryonic stages and from mouse embryonic
stem (ES) cells, and comparing this data with existing
next generation sequence (NGS) data, we were able to
show that the majority of UCEs which have been shown
to act as enhancers during mouse development are also
transcribed and investigated salient properties of these
transcripts.
Results and Discussion
The majority of UCEs are transcribed during mouse
development on a single strand
We decided to systematically ascertain to what extent
UCEs are expressed and whether the corresponding
transcripts can be distinguished from general “transcrip-
tional noise” in the genome. We therefore designed a
custom microarray (CustomarrayTM 12K arrays from
Combimatrix, Mukilteo, WA) encompassing 3 different
probes on each DNA strand of UCEs (of the currently
annotated 481 UCEs, probes could be designed for 475),
as well as a large number of negative controls (exogen-
ous sequences from bacteria and plants, negative
controls used in the Affymetrix platform, rRNAs
sequences), which were used to assess the levels of back-
ground signal. The sequences of all UCE probes were
manually verified to be unique in the genome. This
allowed us to assess reliably the levels of expression
from both strands of UCE genomic regions during
mouse development. In order to define a UCE probe as
being expressed, we took into account only probes
showing signal intensity above the 90th percentile of the
signal distribution in at least two of the three indepen-
dent hybridizations carried out.
The analysis of the microarray data shows that, at
each developmental stage, 30 to 40% of the UCEs ana-
lyzed are transcribed. However, more than half (56%) of
the transcribed UCEs are expressed in at least one of
the tested stages (see Figure 1), and 28% of those are
found within an exonic location (i.e. overlap the exon of
another gene). In total ~50% of transcribed UCEs fall
under the exonic category if those considered “possibly
exonic” are included (i.e. UCEs overlapping ESTs,
mRNAs and gene predictions). Although we have
designed probes on both DNA strands of each UCE,
only 4% of them display signal on both strands, indicat-
ing that most UCEs are parts of transcripts transcribed
from only one strand (see Figure 1A). Of these, the
majority (59%) is transcribed in all stages tested as well
as in ES cells (see Figure 1B). Moreover, when attempt-
ing to identify UCEs with a possible differential expres-
sion across development, we did not find any UCE
showing statistically significant differences in expression
between stages (using a corrected p-value cut-off of
0.05). On the contrary, 83% (117/140) of the UCEs tran-
scribed in all stages shows a significantly stable signal
across the developmental stages tested.
It should be noted that our experiment can only
account for differences across distinct stages of develop-
ment, while previous experiments accounted only for
differences across tissues but not across developmental
stages [12]. Thus, if UCEs are regulating transcription in
a tissue-specific manner these would not be detected in
our study. This data suggests that transcription is a con-
stitutive function in a large fraction of UCEs during
development. The only broad difference that was notice-
able was the generally lower expression levels in ES cells
as compared to other stages, but this was expected since
low levels of expression of a broad range of transcripts
are known to occur in ES cells.
RT-PCR validation indicates more widespread
transcription
We proceeded to validate the microarray results by car-
rying out Reverse Transcriptase (RT)-PCR experiments
on 31 randomly selected UCEs on total RNA extracted
from E14.5 mouse embryos, using 3 independent RNA
preparations [Additional file 1]. The RT-PCR analysis
was considered positive for expression only for UCEs
yielding a specific PCR product validated by sequence
analysis in 3 replicates. We used PCRs without reverse
transcriptase as a control to ensure that we were detect-
ing a transcribed product rather than a genomic DNA
fragment. We observed concordance between the E14.5
microarray data and the RT-PCR results from the same
stage in 18/31 UCEs analyzed (12 of which were
expressed and 6 of which were not expressed). Among
the remaining 13 cases, there are 7 UCEs which were
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s e t( i . e .n o n eo ft h em i c r o a r r a ys t a g e s ,n o ri nt h eR N A -
Seq data discussed later, except for 2 which are found
to be positive in the human microarray dataset), 1
which is found to be negative only by RT-PCR, but con-
firmed by all other methods, 3 which are not confirmed
by the microarray data, but are confirmed by the RNA-
Seq data, and 2 which are confirmed by the ES microar-
ray data [Additional file 1, Additional file 2: Supplemen-
tal Table S1]. The discordance observed is likely due to
several factors. Above all, owing to the fact that the nat-
ure and length of UCE transcripts is not yet elucidated,
both assays are quite limited. PCRs were conducted
with only two pairs of primers per UCE and each UCE
was represented with 3 probes per strand. Thus it is
likely that testing UCEs with further microarray probes
and with further PCR primers would yield different
results and greater concordance. Moreover the stringent
criteria applied to our microarray analysis is likely to
detect a lower number of positives than PCR which is
known to be more sensitive. The overall results indicate
that our microarray results are likely to under-estimate
the number of UCEs that are actually expressed. The
RT-PCR validation data would therefore indicate that
the number of UCEs transcribed at E14.5 is in the range
between approximately 38% (+- 15%, C.I. 95%, as indi-
cated by the microarray data) and 70% (+- 15%, C.I.
95%, which could be extrapolated from the PCR
validation).
We wanted to investigate further the potential nature
of the transcripts encoded by UCEs and thus performed
further RT-PCR analysis for five expressed UCEs (four
intergenic and one exonic, UC 475, used as a control)
on RNA extracted from either the nucleus or the cyto-
plasm of mouse ES cells [Additional file 3]. The results
indicate that only the control exonic UCE can be
detected in the cytoplasmic fraction of RNA, as
expected, while the other UCEs tested (intergenic) were
found only in the nuclear fraction of ES RNA. Further
investigation will be required to ascertain fully the nat-
ure of these transcripts, however this data suggests that
some intergenic UCEs may act as nuclear transcripts,
thus suggesting the possibility that some UCEs might
encode ncRNAs. ncRNAs are known to have an extre-
mely wide variety of functions (reviewed in [15]), how-
ever given the function of UCEs as enhancers it is
tempting to speculate that some of them might act in a
manner similar to previously studied highly conserved
elements which act as both enhancers as well as
ncRNAs [13,14].
UCE transcription and enhancer function overlap
Since we performed our expression analysis during
mouse embryonic development, we were able to
Figure 1 Custom microarrays analysis. A) Bar plot of UCEs expressed across 4 mouse developmental stages tested (ES, E12.5, E14.5 and E16.5)
based on the analysis of our UCE custom microarray. Blue bars indicate UCEs which show expression on a single strand, green columns indicate
UCEs which show expression on both strands B) Venn diagram of UCE transcription results showing the overlap across the 4 stages analyzed.
More than half (n = 140, 56%) of the transcribed UCEs are expressed in all the stages analyzed.
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function of UCEs as long-range enhancers in mouse
embryonic stages [8]. A total of 256 UCEs which were
not part of annotated transcripts (intergenic UCEs) were
tested for enhancer function and are also present in our
microarray design. On this subset of UCEs we were
able, therefore, to compare expression and enhancer
activity. This comparison showed that 20% of all UCEs
tested are transcribed at some developmental stage and
act as enhancers during mouse embryonic development,
indicating that the two functions can coexist within the
same DNA sequence, despite the fact that these regions
are intergenic. In the closest embryonic stage analyzed
(E12.5) 14% of the tested UCEs still present both enhan-
cer and transcription function (i.e. 27% of those acting
as enhancers), indicating that the two functions also can
overlap temporally. Some UCEs still present only one of
the two functions, i.e. 13% are transcribed but without
enhancer activity and 37% behave as enhancers but
show no transcription (see Figure 2).
It must be taken into account that the enhancer data-
set of UCEs was identified based on experiments carried
out at a single developmental stage (E11.5). Therefore,
we cannot exclude that the extent of the overlap will be
greater when considering enhancer function in other
developmental stages. Moreover, due to the different
approaches utilized (temporal for our data and spatial
f o rt h ee n h a n c e rd a t a s e t[ 8 ] )w ec a n n o tc o m p a r e
directly expression levels and enhancer function in the
same tissue at the same developmental stage. Therefore,
we cannot exclude that the enhancer and transcript
function might overlap temporally (i.e. same develop-
mental stage) but not spatially (i.e. different tissue) and
equally we cannot exclude that a broader overlap could
be detected if expression assays had been performed on
specific E11.5 tissues in which enhancer function has
been observed. A further bias can arise from the con-
struct used for the enhancer assays: since some of them
contain two UCE elements within a single construct, it
is not always possible to clearly distinguish the contribu-
tion of each specific UCE element to the enhancer assay
results.
Previous studies have shown that a single ultracon-
served element, contained between the Dlx5 and Dlx6
genes, could act at both DNA and RNA level, and that
the ncRNA encoded within them had an effect on the
coding transcripts within the locus [14]. Our findings
would suggest that the results obtained have a much
wider impact than just a few selected elements, since we
show that transcription from ultraconserved elements
affects more than half of the ultraconserved elements,
and also that the enhancer function attributed to some
UCEs overlaps in the majority of cases with that of
RNA transcript.
Analysis of the genomic context of UCE elements
Given that UCEs are known to be present in both
regions overlapping exons as well as intergenic or intro-
nic regions, we proceeded to verify to what extent the
transcription and enhancer functions observed correlate
with the genomic context in which they are found. We
therefore divided UCEs in the following subgroups: 1)
those previously shown to act as enhancers [8] ("Mouse
Enhancer” dataset), 2) those shown to be transcribed in
our microarray study ("Mouse Transcribed” dataset),
and 3) those displaying both of the above features
("Mouse Enhancer and Transcribed”). We then com-
pared these datasets with the genomic context of UCEs
as previously defined [1]: a) exonic, for UCEs found
within exons of known genes (often referred to also as
genic); b) possibly exonic, for UCEs found within por-
tions of the genome for which gene predictions and/or
EST evidence indicate the possible correspondence with
an exon; c) intronic, for those found within introns and
not classified as possibly exonic, and d) non-genic for
the remaining UCEs (see Figure 3). Most categories did
not show statistically significant enrichment, except for
exonic UCEs which are slightly enriched within the
transcribed set of UCEs as expected (adjusted p-value
0.0460), and significantly impoverished within the set of
UCEs acting as both transcripts and enhancers as well
as among those acting as enhancers only (adjusted
p-values 0.0137 and 0.0005 respectively). This suggests
that UCEs acting as enhancers are more rarely found
w i t h i ne x o n so fk n o w ng e n e s( m o s t l yc o d i n gg e n e s ) .
Transcribed UCEs, on the other hand, although slightly
enriched, as expected, within exons, are present in all
UCEs, irrespective of their genomic context: in fact, the
largest number of transcribed UCEs in absolute terms is
within introns. Taken together these findings suggest
that the enhancer function of UCEs negatively correlates
with their localization within the exons of protein cod-
ing genes despite showing transcription in a significant
percentage of cases, indicating that transcripts covering
UCEs are very likely to perform different function from
traditional coding genes.
Next, we investigated whether transcribed UCEs are
preferentially clustered together arguing for a gene-like
structure. In order to assess this we verified the distance
between all UCEs and compared transcribed UCEs to
non-transcribed UCEs. The results indicate quite the
contrary: transcribed UCEs are more distant from each
other than non-transcribed UCEs at all developmental
stages analyzed [Additional file 4]. While it is known
that some of the UCEs acting as enhancers are quite
close to each other, this result indicates that transcribed
UCEs are less likely than non-transcribed UCEs to
require proximity to other UCEs for their function.
Given the average distances observed among transcribed
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Page 4 of 12Figure 2 UCEs transcription and enhancer function overlap. Overlap between the enhancer dataset (Pennacchio et al, 2006) and the mouse
microarray dataset in all samples analyzed, divided by stage. The yellow portion of each bar indicates UCEs that are only transcribed, the green
portion UCEs that are transcribed and act as enhancers, the blue portion UCEs that are only transcribed.
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of a gene. We note a bimodal distribution among non-
transcribed UCEs with one peak in the 100 kb range,
quite distinct from that of transcribed UCEs, and a sec-
ond peak which aligns well with the distribution of dis-
tances among transcribed UCEs. If distances are
relevant to the function of UCEs, it would be interesting
to verify further whether more distant UCEs which do
not appear to be transcribed in our study are perhaps
transcribed in other tissues/stages or using other valida-
tion means.
Utilizing the genomic context of each UCE element,
we also verified whether UCEs, classified according to
our expression data and published enhancer data, are
found within genes enriched for specific gene ontology
(GO) terms. We therefore focused this analysis only on
UCEs that have been tested both for enhancer function
and for expression during mouse development. The ana-
lysis shows that UCEs which act as enhancers (regard-
less of whether or not they are significantly expressed)
are slightly enriched for genes involved in protein bind-
ing (p-value 0,02 without multiple test correction).
Expressed UCEs, on the other hand, are slightly
enriched for GO terms, related to development and reg-
ulation of biological processes. We also verified the GO
analysis on all UCEs (not only those tested in both stu-
dies). This further analysis confirmed the GO terms that
had been obtained on the smaller dataset and indicated
several additional potential enrichments of UCEs,
including an interesting enrichment for UCEs which
have only evidence for transcription (and not of enhan-
cer function) to be contained in genes involved in RNA
Figure 3 Analysis of UCEs genomic context. Classification of UCEs based on genomic context (exonic = overlapping exons of known genes,
possibly exonic = overlapping gene predictions, intronic = overlapping introns of known genes, non-exonic = not overlapping any of the
above) in comparison with their enhancer function as described by Pennacchio et al, 2006 and transcription function investigated in this study.
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mental Table S3 and S4]. Interestingly a similar enrich-
ment for RNA-related functions has recently been
reported for UCEs which preserve completely identical
sequence across primates and rodents [11]. Given the
small size of this dataset, however, it is not possible to
draw strong conclusions, and no significant enrichment
is found when using multiple testing correction. It could
be interesting in the future study to assess transcrip-
tional levels of a larger set of highly conserved elements
similar to UCEs [11] and verify whether this GO classifi-
cation is confirmed.
RNA-Seq analysis of UCEs indicates significant expression
levels, similar to those of other regions
acting as enhancers
In order to further verify our findings, we also utilized
recently published transcription datasets to validate the
extent to which UCEs might be transcribed. We re-ana-
lyzed two publicly available datasets. First, we used a
microarray dataset obtained from the analysis of several
human wild-type and cancer tissues [12]. From this
s t u d yw eu s e dt h el i s to fU C E sa n n o t a t e da se x p r e s s e d
by the authors. Secondly, we also utilized a recently
published SOLiD sequencing dataset obtained from
high-throughput RNA sequencing (RNAseq) of mouse
embryonic stem cells [16]. The analysis of the RNASeq
dataset indicates that UCEs present significantly higher
RNA-Seq expression levels as compared to random
non-transcribed regions of the genome (Wilcoxon rank
sum test p-value 0.009, see Figure 4B), which provides
further evidence for the fact that their transcription
(shown to be strand-specific in our microarray experi-
ment) is not comparable to general “transcriptional”
noise visible across the genome. The comparison with
random regions of the genome provided us with a cut-
off for bona fide transcribed UCEs based on the RNA-
Seq expression levels.
Figure 4A illustrates a complete comparison of the
datasets analyzed. The addition of the SOLID dataset
(derived from mouse ES cells) indicates that approxi-
mately 58% of all UCEs are transcribed in mouse, in
line with the lower boundary indicated by the microar-
ray of 40% and the higher boundary indicated by the
PCR validations of 70%. Moreover, based on this data,
approximately half of the UCEs acting as enhancers
show evidence of significant, above noise, expression in
mouse in one or more of the datasets utilized. A com-
parison of this data with data obtained in human tissues
allows a further assessment of the phenomenon we
investigate on a mammalian scale. The majority of
U C E s( 6 2 % )t h a ta r ee x p r e s s e di nh u m a nt i s s u e sa r e
also found to be expressed in mouse, indicating that the
prevalence of this function within UCE regions is
broadly conserved across mammals. Notably 32 UCEs
which act as enhancers were not detected to be
expressed in mouse datasets, but are found to be
expressed in human tissues. Although this could be due
to different functions in the two organisms, it is likely to
be due to the tissue-specific nature of the human data-
set, which prompts us to investigate further tissue speci-
ficity of UCE expression in future studies. Interestingly,
Figure 4 UCE classification using External datasets. A) Comparison between the mouse enhancer dataset (Pennacchio et al. 2006) (green
oval), our mouse development microarray dataset, (red oval), the human UCE expression dataset (Calin et al. 2007) (blue oval) and the mouse ES
cell SOLiD expression dataset (Cloonan et al. 2008) (orange oval). B) Comparison of the SOLiD ES cell RNAseq dataset (Cloonan et al. 2008) for
UCEs vs. randomly chosen non-transcribed genomic regions (outliers not shown).
Licastro et al. BMC Genomics 2010, 11:151
http://www.biomedcentral.com/1471-2164/11/151
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enhancers which overlaps with the human dataset is
considerably lower (~30%), indicating that our focus on
mouse development has enabled to identify UCE regions
which exhibit both enhancer and transcript function
more effectively. Only 88 UCEs remain elusive with
regards to their potential function after this analysis.
Supplementary Table s2 [Additional file 2] summarizes
the experimental results obtained for every UCE ele-
ment using our microarray dataset, previous enhancer
screens as well as previous human expression data.
We also verified if we could obtain UCE expression
information from a recently published small RNA
sequencing dataset obtained from human embryonic
stem cells. This experiment utilizes a protocol that fil-
ters RNAs based on their length, selecting for tran-
scripts between 18 and 32 nt long [17]. In this dataset,
however, we did not observe significant small RNA-Seq
expression levels within UCEs, indicating that they are
not likely to transcribe small RNAs (data not shown).
Further evidence reinforcing this notion is that RNAseq
sequences which map to UCEs (filtered for significant
expression levels) always cover 100% of the UCE region.
Taken together, these observations suggest that the
majority of UCEs are not part of short transcripts.
In order to shed further light on the transcription
encoded within UCEs we utilized two recently devel-
oped datasets: a recent study in which a genome-wide
identification of mouse brain enhancers was performed
using p300 ChipSeq [18] as well as a recent study in
which RNASeq was performed on several mouse tissues
including brain [19]. Using these two datasets, we were
able to compare RNASeq- based expression levels in the
brain between random regions of the genome, UCEs,
p300-bound region likely to encode enhancers, brain
enhancers tested in vivo, and coding exons using a
Z - s c o r et e s t( s e eF i g u r e5 ) .T h ea n a l y s i sr e v e a l e dt h a t
UCEs present levels of expression that are very similar
to those of in vivo tested enhancers (p-value 0.7), resem-
ble p300-bound regions (p-value 0.012), while they are
higher and significantly different from those of random
non coding regions of the genome (p-value 1.179978e-
25) and lower than and significantly different from those
of coding exons (p-value 5.29889e-14).
This data would confirm that the majority of UCEs in
which we can detect expression are likely to encode
t r a n s c r i p t st h a ta r et r a n s c r i b e da ts i g n i f i c a n ta n d ,c o m -
parable levels with respect to those of other enhancer
regions, but lower to those of coding exons. It should be
noted, however, that given that our data indicates that
UCEs could also encode nuclear transcripts, RNASeq
results will be heavily influenced by the RNASeq proto-
col used and the resulting proportion of nuclear tran-
scripts within the RNA sample sequenced. Given that
the data utilized was made using a Poly(A)+ enrichment
step, it is likely that the real levels of expression of the
nuclear transcripts encoded by UCEs are under-
estimated.
In order to further investiga t et h en a t u r eo ft h et r a n -
scripts derived from transcribed UCEs we verified the
RNA-Seq expression levels of ES cells in the regions
proximal to these elements (500 bp upstream and down-
stream of each UCE). Our analysis indicates that the
majority (60%) of UCEs that were found to be expressed
in ES cells using the RNA-Seq data also present signifi-
cant expression levels in the surrounding regions. Half
of the UCEs expressed in ES cells present significant
levels of transcription on both sides of the element (70%
intronic), while 10% present transcription on one side
only (80% intronic). The remaining 40% (90% intronic)
do not present transcription in nearby regions. In con-
trast, only 3% of the UCEs found not to be transcribed
in ES cells using RNA-Seq presented transcription in
the proximal 500 bp regions, of which only 2 UCEs
(0.5%) appear to be transcribed both upstream and
downstream. Interestingly most of the latter (85%) were
exonic, indicating ultra-conserved exons which might be
expressed in other stages/tissues, but whose surrounding
regions are expressed in ES cells. This result indicates
that in the majority of cases the UCE expression investi-
gated in this study might be representative of longer,
underlying transcripts which span across and beyond
t h eU C Er e g i o n .W ea l s oi n s p e c t e dt h em i c r o a r r a y
results (since we had designed probes in the surround-
ing regions) and obtained similar results, i.e. 44% of
UCEs found to be transcribed in ES cells present
expression in the surrounding regions (56% of UCEs in
E12, 42% in E14 and 39% in E16).
Although our data clearly indicates that transcription
is an important function of UCE elements, and that this
function clearly overlaps with that of enhancer, it
r e m a i n st ob eu n d e r s t o o dt ow h a te x t e n tt h i se x p l a i n s
the high evolutionary constrained found in these
sequences. The fact that p300-bound regions and in
vivo tested enhancers exhibit similar levels of transcrip-
tion to UCEs would suggest that the co-occurrence of
the two functions alone does not explain the constraint.
On the other hand, much more in depth investigation
of nuclear, tissue-specific transcription should be ana-
lyzed before drawing conclusions with regards to their
similarity to less constrained enhancers.
It was shown recently that there is a much larger
number or regions that are likely to be under similar
evolutionary constraint to UCEs, despite their shorter
size [11]. Only an in depth analysis of transcriptional
levels of a large set of enhancers and conserved regions
(highly conserved as well as ultraconserved) performed
on nuclear and cytoplasmic RNA is likely to provide
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UCEs.
Conclusion
In conclusion, we report that the majority of UCEs are
expressed throughout mouse development in single-
stranded transcripts. Based on our preliminary charac-
terization of these transcripts the RNAs encoded within
U C E sa r eu n l i k e l yt ob es h o r tR N A sa n ds o m eo ft h e m
might encode nuclear RNAs. A significant fraction of
UCEs appears to act as both enhancers and RNAs dur-
ing mouse development and RNASeq data indicates that
the levels of transcription found in UCEs are likely to be
similar to other enhancer regions in the mouse genome.
This data provides further evidence and clues with
regards to their functional complexity, and reinforces
the possibility that the elevated constraint on their
sequence might arise from multiple concurrent
functions.
Methods
RNA Extraction
RNA extraction was performed on mouse embryonic
stem (ES) cells, E12.5, E14.5 and E16.5 C57/Bl6 mouse
embryos. Mouse embryos were dissected from pregnant
females at stages E12.5, E14.5 and E16.5. The dissected
embryos were immediately frozen in dry ice and then
RNA was isolated using Trizol (Invitrogen) and purified
using the RNeasy mini kit (Qiagen). Three independent
RNA extractions were performed for each stage and the
extracted nucleic acids were treated for DNA
contamination with the DNA-free Kit (Quiagen) to pre-
vent DNA carryovers. The cytoplasmic fraction of RNA
from ES cells was extracted according to the Maniatis
protocol. The quality and concentration of the RNA was
determined by measuring the absorbance at 260 and
280 nm using the Nanodrop nd-1000 Spectrophot-
ometer while the RNA integrity was determined using
the Agilent Bioanalyzer RNA 6000 Nano chip according
to manufacturer instructions.
ES Cell Culture
The feeder-independent mouse Embryonic Stem (ES)
E14 Tg2A.4 cell lines were grown on gelatin (0.1%),
plastic-coated petri dishes in Dulbecco’s modified Eagle
medium (DMEM, Invitrogen) supplemented with 15%
(vol/vol) heat-inactivated Fetal Bovine Serum (FBS,
Euroclone), 2 mM L-glutamine, 1 mM MEM sodium
pyruvate, 0.1 mM 2- mercaptoethanol and 1,000 units/
ml leukemia inhibitor factor at 37°C in a humidified
chamber supplemented with 5% CO2.
Reverse Transcriptase RT PCR
Reverse Transcriptase (RT)-PCR was performed in tri-
plicate on total RNA extracted from E14.5 mouse
embryos. The UCEs were chosen in a different labora-
tory from the one performing the RT-PCR experiments,
without communicating the result expected on the basis
of the microarray data. To prepare cDNA synthesis, we
used the Quantitect Reverse Transcription kit (Qiagen,
Inc.) starting from 1 μg of DNAse-treated RNA. To
further exclude genomic DNA contamination, RT- (no
Figure 5 RNASeq-based expression comparison between random regions, UCEs, p300-bound region and coding exons. Ultraconserved
elements present polyA+ RNASeq based expression levels which are significantly different from random non-coding regions as well as from
coding regions, but not from p300 bound regions. Analysis of RNASeq data derived from mouse brain (A. Mortazavi et al, 2008) on several types
of genomic regions, i.e. ultraconserved elements (red), randomized set of p300 bound regions (blue, Pennacchio et al, 2009), in vivo tested
enhancer regions bound by p300 (green, Pennacchio et al, 2009), random non coding regions in the genome (white) and random coding exons
(black).
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Page 9 of 12reverse transcriptase added) reactions were used as
negative controls. Oligonucleotide sequences and PCR
conditions are available upon request. Only RT-PCRs,
which were positive in all three replicas, negative in the
RT- and confirmed by sequencing analysis were consid-
ered as positive.
Custom Microarray Design
The electrochemically synthesized oligonucleotide
microarrays used in this study are CustomarrayTM 12K
arrays (Combimatrix, Mukilteo, WA). The oligonucleo-
tide sequences and arrays were designed using as a
reference the murine genome sequence from the
Ensembl release 46. The arrays consist of ~12,000 oligo-
nucleotide probes. For each UCE, three probes were
designed, on both DNA strands of the UCE element.
We mapped the published UCE sequence to the
unmasked murine genome and, through the use of bio-
perl scripts, we also retrieved the sequences 500 bp
upstream and downstream of the mapped UCE and
designed probes in these regions. Moreover if the UCE
mapped inside known exons, we designed probes also
for the overlapping exon while if the UCE mapped
between exons, we designed probes for the nearest
upstream and downstream exons. The probes have been
further selected according to their melting temperature
using the Combimatrix ProbeWeaverTM Software. The
dataset of all UCEs analyzed, their sequences and the
probes used is available at http://biodev.cbm.fvg.it/cgi-
bin/uce/total_uce.pl. The microarray design and data
has been deposited to the GEO database, as dataset
GSE19371.
Microarray Labeling and hybridization
Biotin-labeled cRNAs was produced with Illumina Total
Prep RNA Amplification Kit (Ambion), according to
manufacturer protocol, starting from extracted RNA.
The arrays were enclosed within the supplied hybridiza-
tion chambers, filled with H2O and incubated in a
rotisserie hybridization oven for 10 min at 65°C to
remove adsorbed oxygen from the slides. The arrays
were then incubated at 45°C for 30 min in prehybridiza-
tion solution (6× SSPE (Ambion), 0.05% Tween-20
( S i g m aA l d r i c h ,S t .L o u i s ,M O ) ,2 0m ME D T A
(Ambion), 5× Denhardt’s solution (Sigma Aldrich), 100
ng/μl salmon sperm DNA (Sigma Aldrich), 0.05% SDS
(Sigma Aldrich)). Biotin-labeled RNA was added to the
hybridization buffer (100 μl total volume, 6! SSPE, 0.05%
Tween-20, 20 mM EDTA, 25% formamide, 100 ng/μl
salmon sperm DNA, 0.05% SDS) heated at 95°C for
3 min, chilled briefly on ice, added to microarray slides,
and incubated at 45°C overnight. Slides were washed for
five successive washes of 5 min each in Wash I (6!
SSPE, 0.05% Tween-20), Wash II (3× SSPE, 0.05%
Tween-20), Wash III (0.5× SSPE, 0.05% Tween-20),
Wash IV (2× PBS, 0.1% Tween-20), and Wash V (2×
PBS (Sigma Aldrich). Wash I was performed at 45°C
with all subsequent washes at room temperature. The
slide was removed from the hybridization chamber then
immediately stained with HRP using biotin-avidin chem-
istry according to manufacture protocol and read using
a ElectraSenseTM Reader using the revelation solution
Microarray Analysis
The raw data signal was exported from the ElectraSense
Analysis Software, loaded into the R/Bioconductor pro-
g r a m[ 2 0 ] ,t h a n k st ot h eB i o b a s ep a c k a g e ,a n df i n a l l y
converted into a Bioconductor Expressionset Object.
Gene expression data were normalized by Quantile
regression [21]. Probe signal was considered positive if
present in at least two of three independent hybridiza-
tions above the 90th percentile of the signal distribution.
We also required for the signal to be higher than the
average of the negative probe signal + 2 standard devia-
tions, which was the case for all probes selected, given
the 90th percentile cut-off applied The Limma package
[22] was used to perform the statistical analysis to iden-
tify differentially expressed UCEs. A cut off after the
adjustment of P-values to control the false discovery
rate (FDR) [23] was set to p < 0.05 as set out by the
MAQC consortium guidelines [24]. In order to identify
constitutively expressed UCEs (i.e. with stable signal
across development) we used a method previously devel-
oped by our lab [25]. Briefly this involved calculating the
MFC (maximal fold change), i.e. the ratio of the maxi-
mum and minimum expression values for all microar-
rays performed in the experiment, and the CV, i.e. the
coefficient of variation. We considered as constitutively
expressed only those UCEs having: MFC < 2, CV < 0.05,
an average signal intensity larger than the 5th percentile
of the distribution of the signals (to avoid the classifica-
tion of UCEs with very low signals) and a signal inten-
sity larger than two standard deviations from the mean
of the negative probes. For the Gene Ontology (GO)
analysis we performed two analyses: one [Additional file
2: Supplemental Table S4] which focused only on UCEs
that have been tested for both Enhancer and Transcrip-
tion activity, another [Additional file 2] which analyzed
GO context of all UCEs, regardless of whether they had
been tested for enhancer and/or transcription activity.
The analysis has been performed within the Bioconduc-
tor environment using the packages GO.db version 2.2.0
and GOstats [26] version 2.6.0 with the hyperGTest
function.
Selection of random non-transcribed region
In order to obtain a comparable dataset of random non-
transcribed regions of the genome for each UCE
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Page 10 of 12analyzed, we selected randomly 3 regions of the same
length with no evidence of transcription and/or presence
of repeated sequences. We exploited the annotation of
the Ensembl database (mouse genome, version 49) and
selected regions presenting no ‘dna align features’ (i.e.
no alignment with known cDNAs, ESTs, etc) with a
score higher than 75, no ‘protein align features’,n o‘pre-
diction transcripts’ and no ‘repeat features’ overlapping
them. Finally we only selected regions that did not con-
tain ‘N’ nucleotides.
UCE classification using External datasets
We classified UCEs as “exonic”,i . e .i ft h e yo v e r l a p p e d
known exons, “intronic”, if they fell within introns of
known genes, “possibly exonic” if they overlapped
regions which present some evidence of genes (e.g.
gene predictions, EST alignments, etc) and “non exo-
nic” if they did not fall in any of the above. A single
nucleotide of overlap was considered sufficient for
UCEs to be classified in the above categories. We then
compared these annotation categories among 4 data-
sets: a “UCE” dataset, containing all UCEs; a “Mouse
Transcribed UCE” dataset, containing UCEs which
were found to be expressed during mouse development
using our custom microarray experiment, a “Mouse
Enhancer UCE” dataset, containing UCEs which have
been shown to act as enhancers [8], and a “Mouse
Transcribed and Enhancer” dataset, containing UCEs
which were found to act as enhancers previously [8] as
well as found to be expressed during mouse develop-
ment in our experiment. On each of these sets we per-
formed a Perfect test followed by Hochberg correction
to determine if the proportions of annotation cate-
gories deviated significantly from the proportions
found in the complete UCE dataset. The dataset of
UCEs tested for enhancer activity was downloaded
from the webpage http://enhancer.lbl.gov/ and has
been mapped to UCEs sequences using wblast tool and
Perl parsing scripts. The dataset of UCEs expressed
above background levels in 19 human normal tissues
[12] was downloaded from the webpage of the manu-
script. Expressed UCEs were selected as annotated by
the authors (i.e., those displaying a signal higher than
the average of blank spots on the array + 2 standard
deviations). The RNA-Seq dataset obtained from
mouse embryonic stem cell (using SOLiD sequencing)
was downloaded from the Supplemental Data of the
manuscript [16], using the “ES junction” BED track.
Forebrain, Midbrain and Limb p300 Peak bound
regions were downloaded from the Supplementary
Data of the manuscript [18] and filtered for FDR lower
than 0.01 as suggested in the manuscript. Solexa RNA-
seq normalized wigglegrams of unique reads from
adult brain, liver and skeletal tissues were downloaded
from the Supplementary Methods of the manuscript
[19]. Reads from the above experiments were mapped
to UCE regions, randomly chosen mouse exons
(mouse genome, version 49), random non-transcribed
regions, and p300 bound regions using a custom R
script. The comparison of RNASeq- based expression
levels in the brain between random regions of the gen-
ome, UCEs, p300-bound regions likely to encode
enhancers, brain enhancers tested in vivo, and coding
exons has been performed using a Z test with 10,000
random sampling.
Additional file 1: Supplementary Figure 1. The summary of results for
PCR tested UCEs.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
151-S1.TIFF]
Additional file 2: Supplementary Tables. Table 1,2 The summary
expression results for each UCE. Table 3,4 Tables summarizing the Gene
Ontology Analysis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
151-S2.XLS]
Additional file 3: Supplementary Figure 2. RT-PCR analysis for five
expressed UCEs on RNA extracted from either the nucleus or the
cytoplasm of mouse ES cells.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
151-S3.TIFF]
Additional file 4: Supplementary Figure 3. The analysis of distance
between UCEs
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
151-S4.PDF]
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